Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Beatty

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Scientific Data|June 23, 2025
Long-Term Sweat Testing Dataset for Second-Life BatteriesMatthew Beatty, Dani Strickland, Joe Warren, et al.
Transplantation and Cellular Therapy|January 7, 2022
Early Recovery of Myeloid-Derived Suppressor Cells After Allogeneic Hematopoietic Transplant: Comparison of Post-Transplantation Cyclophosphamide to Standard Graft-Versus-Host Disease ProphylaxisBenjamin Oshrine, Patrick Innamarato, Holly Branthoover, et al.
Frontiers in Immunology|March 15, 2021
The Factors Affecting Expansion of Reactive Tumor Infiltrating Lymphocytes (TIL) From Bladder Cancer and Potential Therapeutic ApplicationsAhmet Murat Aydin, Brittany L Bunch, Matthew Beatty, et al.
BMC Cancer|June 30, 2021
Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumorsPatrick Innamarato, Jennifer Morse, Amy Mackay, et al.
BMJ Open Quality|December 7, 2023
Digital health coaching to improve patient preparedness for elective lower limb arthroplasty: a quality improvement projectNicola Powley, Garry A Tew, James Durrand, et al.
Journal for Immunotherapy of Cancer|December 11, 2020
Systemic and intravesical adoptive cell therapy of tumor-reactive T cells can decrease bladder tumor growth in vivoBrittany L Bunch, Jennifer Morse, Sarah Asby, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
PETIL: Predicting Expansion of Tumor Infiltrating Lymphocytes for the Adoptive Cell Immunotherapy in Bladder CancersKayode D Olumoyin, Ahmet Murat Aydin, Sarah Bazargan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 3, 2020
Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell TherapyPatrick Innamarato, Krithika Kodumudi, Sarah Asby, et al.
International Immunopharmacology|February 26, 2021
Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patientsAhmet Murat Aydin, MacLean Hall, Brittany L Bunch, et al.
JMIR Mhealth and Uhealth|February 16, 2021
Development and Validation of Risk Scores for All-Cause Mortality for a Smartphone-Based "General Health Score" App: Prospective Cohort Study Using the UK BiobankAshley K Clift, Erwann Le Lannou, Christian P Tighe, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Scientific Data|June 23, 2025
Long-Term Sweat Testing Dataset for Second-Life BatteriesMatthew Beatty, Dani Strickland, Joe Warren, et al.
Transplantation and Cellular Therapy|January 7, 2022
Early Recovery of Myeloid-Derived Suppressor Cells After Allogeneic Hematopoietic Transplant: Comparison of Post-Transplantation Cyclophosphamide to Standard Graft-Versus-Host Disease ProphylaxisBenjamin Oshrine, Patrick Innamarato, Holly Branthoover, et al.
Frontiers in Immunology|March 15, 2021
The Factors Affecting Expansion of Reactive Tumor Infiltrating Lymphocytes (TIL) From Bladder Cancer and Potential Therapeutic ApplicationsAhmet Murat Aydin, Brittany L Bunch, Matthew Beatty, et al.
BMC Cancer|June 30, 2021
Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumorsPatrick Innamarato, Jennifer Morse, Amy Mackay, et al.
BMJ Open Quality|December 7, 2023
Digital health coaching to improve patient preparedness for elective lower limb arthroplasty: a quality improvement projectNicola Powley, Garry A Tew, James Durrand, et al.
Journal for Immunotherapy of Cancer|December 11, 2020
Systemic and intravesical adoptive cell therapy of tumor-reactive T cells can decrease bladder tumor growth in vivoBrittany L Bunch, Jennifer Morse, Sarah Asby, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
PETIL: Predicting Expansion of Tumor Infiltrating Lymphocytes for the Adoptive Cell Immunotherapy in Bladder CancersKayode D Olumoyin, Ahmet Murat Aydin, Sarah Bazargan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 3, 2020
Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell TherapyPatrick Innamarato, Krithika Kodumudi, Sarah Asby, et al.
International Immunopharmacology|February 26, 2021
Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patientsAhmet Murat Aydin, MacLean Hall, Brittany L Bunch, et al.
JMIR Mhealth and Uhealth|February 16, 2021
Development and Validation of Risk Scores for All-Cause Mortality for a Smartphone-Based "General Health Score" App: Prospective Cohort Study Using the UK BiobankAshley K Clift, Erwann Le Lannou, Christian P Tighe, et al.
Pageof 3